Advertisement

Correlates of Nonmedical Prescription Opioid Use Among U.S. Adolescents

Published:September 26, 2019DOI:https://doi.org/10.1016/j.amepre.2019.05.006

      Introduction

      The purpose of this study is to assess risk factors, including other substance use, for nonmedical prescription opioid use among U.S. adolescents.

      Methods

      A secondary data analysis of the 2017 Youth Risk Behavior Survey was conducted (n=10,175) in 2018. The outcome was nonmedical prescription opioid use. Predictor variables included other substance use, mood, sleep, academic performance, and demographic characteristics. Survey-weighted procedures in SAS, version 9.4 were used, and an adjusted logistic regression model was conducted.

      Results

      Among the sampled adolescents, 13.8% (95% confidence limit=12.4%, 15.3%) reported nonmedical prescription opioid use. Nonmedical prescription opioid use was more likely among participants aged 15 years (versus 16 years), American Indian/Alaskan Natives, and those who reported being sad or hopeless. All other substance use was significantly associated with increased odds of nonmedical prescription opioid use. Nonmedical prescription opioid use was 1.5 times more likely among electronic vapor users (AOR=1.58, 95% CI=1.34, 1.86), 2 times more likely among cigarette (AOR=2.49, 95% CI=2.16, 2.88) and marijuana users (AOR=2.45, 95% CI=2.05, 2.93), and almost 3 times as likely among alcohol users (AOR=2.98, 95% CI=2.18, 4.07).

      Conclusions

      Study findings suggest a need for more interventions for nonmedical prescription opioid use among adolescents in the U.S. Information on nonmedical prescription opioid use should be added to all substance use prevention programs for adolescents. Moreover, future research needs to identify longitudinal predictors of adolescent nonmedical prescription opioid use to inform prevention efforts.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

      1. Lipari RN, Van Horn SL, Hughes A, Williams M. State and substate estimates of nonmedical use of prescription pain relievers. CBHSQ Rep. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. www.samhsa.gov/data/sites/default/files/report_3187/ShortReport-3187.html. Published 2017. Accessed August 20, 2018.

      2. Substance Abuse Center for Behavioral Health Statistics and Quality. Results from the 2016 national survey on drug use and health: detailed tables. SAMHSA.www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.htm. Accessed August 31, 2018.

      3. Hughes A, Williams MR, Bose LJ, et al. Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review. www.samhsa.gov/data/. Accessed August 20, 2018.

      4. Johnston LD, Miech RA, O'Malley PM, et al. Monitoring the future national survey results on drug use, 1975-2017. In: Overview, Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2018.

        • Kandel DB
        • Hu MC
        • Griesler P
        • Wall M
        Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances.
        Drug Alcohol Depend. 2017; 178: 501‒511
        • Beaudoin FL
        • Straube S
        • Lopez J
        • Mello MJ
        • Baird J
        Prescription opioid misuse among ED patients discharged with opioids.
        Am J Emerg Med. 2014; 32: 580‒585
        • Blanco C
        • Alderson D
        • Ogburn E
        • et al.
        Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991‒1992 and 2001‒2002.
        Drug Alcohol Depend. 2007; 90: 252‒260
        • Svendsen K
        • Fredheim OM
        • Romundstad P
        • Borchgrevink PC
        • Skurtveit S
        Persistent opioid use and socio-economic factors: a population-based study in Norway.
        Acta Anaesthesiol Scand. 2014; 58: 437‒445
        • Ayers CG
        • Pontes NM
        • Pontes MC
        Understanding the nonmedical use of prescription medications in the U.S. high school adolescents.
        J Sch Nurs. 2017; 33: 269‒276
        • Clayton HB
        • Lowry R
        • August E
        • Jones SE
        Nonmedical use of prescription drugs and sexual risk behaviors.
        Pediatrics. 2016; 137e20152480
        • Divin AL
        • Zullig KJ
        The association between non-medical prescription drug use and suicidal behavior among United States adolescents.
        AIMS Public Health. 2014; 1: 226‒240
        • Vaughn MG
        • Nelson EJ
        • Salas-Wright CP
        • Qian Z
        • Schootman M
        Racial and ethnic trends and correlates of non-medical use of prescription opioids among adolescents in the United States 2004‒2013.
        J Psychiatr Res. 2016; 73: 17‒24
        • McCabe SE
        • West BT
        • Boyd CJ
        Medical use, medical misuse, and nonmedical use of prescription opioids: results from a longitudinal study.
        Pain. 2013; 154: 708‒713
        • McCabe SE
        • Schulenberg JE
        • O'Malley PM
        • Patrick ME
        • Kloska DD
        Nonmedical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study.
        Addiction. 2014; 109: 102‒110
        • Miech R
        • Johnston L
        • O'Malley PM
        • Keyes KM
        • Heard K
        Prescription opioids in adolescence and future opioid misuse.
        Pediatrics. 2015; 136: 1169‒1177
        • National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Adolescent and School Health, CDC
        YRBS data user's guide.
        Published 2017
        • Kann L
        • McManus T
        • Harris WA
        • et al.
        Youth risk behavior surveillance—United States, 2017.
        MMWR Surveill Summ. 2018; 67: 1-114
        • Howard MM
        • Weiler RM
        • Haddox JD
        Development and reliability of items measuring the nonmedical use of prescription drugs for the Youth Risk Behavior Survey: results from an initial pilot test.
        J Sch Health. 2009; 79: 554‒560
        • Swaim RC
        • Stanley LR
        Substance use among American Indian youths on reservations compared with a national sample of U.S. adolescents.
        JAMA Netw Open. 2018; 1e180382
        • de Ravello L
        • Jones SE
        • Tulloch S
        • Taylor M
        • Doshi S
        Substance use and sexual risk behaviors among American Indian and Alaska Native high school students.
        J Sch Health. 2014; 84: 25‒32
        • Osborne V
        • Serdarevic M
        • Crooke H
        • Striley C
        • Cottler LB
        Non-medical opioid use in youth: gender differences in risk factors and prevalence.
        Addict Behav. 2017; 72: 114‒119
        • Das JK
        • Salam RA
        • Arshad A
        • Finkelstein Y
        • Bhutta ZA
        Interventions for adolescent substance abuse: an overview of systematic reviews.
        J Adolesc Health. 2016; 59: S61‒S75
        • Graham JW
        Missing data analysis: making it work in the real world.
        Annu Rev Psychol. 2009; 60: 549‒576